Le Lézard
Classified in: Health, Business
Subjects: CCA, FVT

GLOBE LIFE INC. ANNOUNCES FOURTH QUARTER 2021 EARNINGS RELEASE AND CONFERENCE CALL


MCKINNEY, Texas, Jan. 26, 2022 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will release Fourth Quarter 2021 earnings after the market closes on Wednesday, February 2, 2022.  At that time a copy of the Company's Q4 - 2021 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at https://investors.globelifeinsurance.com/ under Financial Reports and Other Financial Information.  In conjunction with the Fourth Quarter 2021 Earnings Release of Globe Life Inc. you are invited to listen to a conference call that will be broadcast live over the Internet on Thursday, February 3, 2022 at 11:00 am Eastern (10:00 am Central).

Fourth Quarter Conference Call
Thursday, February 3, 2022
11:00 a.m. (Eastern)

Listen live and as a replay at https://investors.globelifeinsurance.com/ under Calls and Meetings

or

Call-In Number: 

1-646-828-8193

 (Pass Code:  Globe Life Inc.)

Globe Life Inc. is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct to consumer, and exclusive and independent agencies. 

SOURCE Globe Life Inc.


These press releases may also interest you

at 18:11
Today, the U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. "We continue to do everything in our power as...

at 18:06
Salmonella Lawyer Jory Lange has been retained by victims of the Buba Noodle Bar Salmonella Outbreak. At least 7 people have gotten Salmonella food poisoning in this outbreak.  "The scary thing about this outbreak is, as a consumer, there's nothing...

at 18:05
ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic cell therapies has joined as a full partner the Accelerating Medicines Partnership®...

at 17:16
Yesterday, Governor Ned Lamont signed House Bill 5500 (HB 5500) into law which includes provisions to establish a permanent Rare Disease Advisory Council (RDAC) in the state of Connecticut. Connecticut established a temporary rare disease task force...

at 17:11
Abbott to release limited quantities of EleCare® branded specialty formulasProduct will be released immediately free of charge to children in needParents and caregivers in urgent need should contact their healthcare professionals or Abbott at...

at 17:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new study data demonstrating the ability of its TissueCypher® Barrett's Esophagus test to independently predict malignant...



News published on 26 january 2022 at 20:15 and distributed by: